you are here: HomeNewsBse
bse
Jump to
11607 Results Found
  • Investor wealth jumps Rs 1.91 lakh crore as markets rally Jun 18, 2020 07:00 PM IST

    Investor wealth jumps Rs 1.91 lakh crore as markets rally

    The rally in the equity market helped the market capitalisation of BSE-listed companies gain Rs 1,91,540.25 crore to Rs 1,35,48,847.54 crore.

  • Alembic Pharma gets USFDA nod for generic chronic iron overload treatment tablets Jun 16, 2020 01:15 PM IST

    Alembic Pharma gets USFDA nod for generic chronic iron overload treatment tablets

    The company has received the final approval from the United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Deferasirox tablets in the strength of 180 mg, Alembic Pharmaceuticals said in a BSE filing.

  • Zydus Cadila gets USFDA approval to market generic version of Deferasirox tablets Jun 16, 2020 11:20 AM IST

    Zydus Cadila gets USFDA approval to market generic version of Deferasirox tablets

    The approval by the US Food and Drug Administration (USFDA) for Deferasirox tablets is for multiple strengths of 90 mg, 180 mg and 360 mg, Cadila Healthcare said in a regulatory filing.

  • Slideshow | Market breaks two-week winning streak; Hindustan Unilever, Bajaj Finance add to market value Jun 14, 2020 08:38 AM IST

    Slideshow | Market breaks two-week winning streak; Hindustan Unilever, Bajaj Finance add to market value

    While FIIs sold equities worth Rs 1,731.81 crore, DIIs sold equities worth of Rs 400.06 crore in the week that ended on June 12.

  • Zydus Cadila gets USFDA nod for generic antiviral drug Jun 05, 2020 01:08 PM IST

    Zydus Cadila gets USFDA nod for generic antiviral drug

    The company has received final approval from the US Food and Drug Administration (USFDA) to market Atazanavir capsules in strengths of 150 mg, 200 mg and 300 mg, Zydus Cadila said in a statement.

  • Hindustan Copper board approves increase in borrowing limit to Rs 1,350 crore Jun 02, 2020 03:15 PM IST

    Hindustan Copper board approves increase in borrowing limit to Rs 1,350 crore

    The approval was granted during the board meeting held on Monday, Hindustan Copper said in a filing to BSE.

  • Strides Pharma gets USFDA nod for generic ointment to treat skin conditions Jun 02, 2020 12:20 PM IST

    Strides Pharma gets USFDA nod for generic ointment to treat skin conditions

    The approval is granted to the company's step-down wholly owned subsidiary, Strides Pharma Global, Singapore, by the United States Food and Drug Administration (USFDA) for triamcinolone acetonide ointment USP, 0.05 per cent, Strides Pharma Science said in a regulatory filing.

  • Mahindra Finance to raise up to Rs 3,500 crore via rights issue Jun 01, 2020 03:45 PM IST

    Mahindra Finance to raise up to Rs 3,500 crore via rights issue

    The board of directors in its meeting on Monday considered and approved a fundraising of up to Rs 3,500 crore through rights issue, Mahindra Finance said in a regulatory filing.

  • Manappuram Finance to raise up to Rs 500 crore via NCDs Jun 01, 2020 11:57 AM IST

    Manappuram Finance to raise up to Rs 500 crore via NCDs

    "The financial recourse and management committee of the board of directors of the company held on June 1...has approved the allotment of 5,000 secured redeemable non-convertible debentures ...aggregating to Rs 5,00,00,00,000,... on a private placement basis to be listed on the BSE," Manappuram Finance said in a regulatory filing.

  • Future Retail to raise Rs 650 crore via NCDs to reduce debt May 27, 2020 01:24 PM IST

    Future Retail to raise Rs 650 crore via NCDs to reduce debt

    “The Board has also authorised the Committee of Directors to decide on matters and transactions relating to aforesaid proposed issuance and allotment of NCDs including but not limited to finalisation and approval of terms and conditions of issue, number of NCDs and timing of the issue from time to time,” the filing said.

  • Glenmark gets USFDA nod to market generic drug for muscle pain May 27, 2020 10:59 AM IST

    Glenmark gets USFDA nod to market generic drug for muscle pain

    Glenmark Pharmaceuticals Inc, USA has been granted final approval by the US Food and Drug Administration (USFDA) for Chlorzoxazone tablets USP, in strength of 375 mg and 750 mg, the drug maker said in a statement.

  • BSE launches e-KYC services on StAR MF for seamless onboarding of investors May 26, 2020 04:50 PM IST

    BSE launches e-KYC services on StAR MF for seamless onboarding of investors

    Besides, the exchange is planning to provide e-KYC services to stock brokers and other approved intermediaries in the near future, BSE said in a statement.

  • Buy BSE; target of Rs 630: Motilal Oswal May 25, 2020 09:21 PM IST

    Buy BSE; target of Rs 630: Motilal Oswal

    Motilal Oswal is bullish on BSE has recommended buy rating on the stock with a target price of Rs 630 in its research report dated May 21, 2020.

  • BSE posts net loss of Rs 1.94 crore in Q4 May 21, 2020 10:30 PM IST

    BSE posts net loss of Rs 1.94 crore in Q4

    Total income dropped to Rs 155.79 crore in the fourth quarter ended March 31, 2020, from Rs 182.08 crore in the same period preceding fiscal.

  • CESC raises Rs 300 crore via NCDs May 21, 2020 12:45 PM IST

    CESC raises Rs 300 crore via NCDs

    "3,000 Non-Convertible Debentures of face value of Rs 10 lakh each aggregating to Rs 300 crore have been allotted today, on a private placement basis, to ICICI Bank Ltd," according to a regulatory filing.

  • Cipla gets final nod from USFDA for migraine treatment nasal spray May 21, 2020 09:48 AM IST

    Cipla gets final nod from USFDA for migraine treatment nasal spray

    "It has received final approval for its Abbreviated New Drug Application (ANDA) for Dihydroergotamine Mesylate nasal spray 4mg/mL from the United States Food and Drug Administration (USFDA) with a competitive generic therapy (CGT) designation," the company said in a filing to BSE.

  • CESC board panel approves raising Rs 300 crore via NCDs May 20, 2020 01:48 PM IST

    CESC board panel approves raising Rs 300 crore via NCDs

    "An issue of 3,000 NCDs having a face value of Rs 10 lakh each for cash at par aggregating to Rs 300 crore, on a private placement basis has been approved today," the company said in a BSE filing.

  • Tata Steel raises Rs 1,000 crore via NCDs May 20, 2020 01:40 PM IST

    Tata Steel raises Rs 1,000 crore via NCDs

    "The Committee of Directors has today approved allotment of 10,000 –- 8.25 per cent unsecured, rated, listed, redeemable, NCDs of face value Rs 10,00,000 each, for cash aggregating to Rs 1,000 crore, to identified investor on private placement basis," Tata Steel said in a filing to BSE.

  • BSE cuts annual listing fee on the BSE SME platforms by 25% May 18, 2020 04:13 PM IST

    BSE cuts annual listing fee on the BSE SME platforms by 25%

    As per the release, the revised listing fee structure will be applicable for the existing companies as well as for all the firms awaiting to be listed on BSE.

  • Eight of top-10 firms lose Rs 1.37 lakh cr in market cap; RIL hit hard May 17, 2020 01:49 PM IST

    Eight of top-10 firms lose Rs 1.37 lakh cr in market cap; RIL hit hard

    RIL's market cap plunged Rs 65,232.46 crore to Rs 9,24,855.56 crore.

  • Eight of top-10 firms lose Rs 2.50 lakh cr in m-cap May 10, 2020 10:33 AM IST

    Eight of top-10 firms lose Rs 2.50 lakh cr in m-cap

    In the top-10 list, only Reliance Industries Ltd and Bharti Airtel managed to close the trading week with gains.

  • Biocon gets establishment inspection report from USFDA for Bengaluru plant May 08, 2020 01:11 PM IST

    Biocon gets establishment inspection report from USFDA for Bengaluru plant

    The company has received the EIR from the US Food and Drug Administration (USFDA) for the pre-approval and good manufacturing practice inspection of its small molecules active pharmaceutical ingredient (API) manufacturing facility at Biocon Park SEZ, Bengaluru, it said in a filing to BSE.

  • Dr Reddy's gets USFDA inspection closure report for Srikakulam plant May 08, 2020 12:05 PM IST

    Dr Reddy's gets USFDA inspection closure report for Srikakulam plant

    The US Food and Drug Administration (USFDA) had issued a warning letter to the facility in November, 2015, after inspecting it in 2014.

  • After a bout with NCLT, this stock has rallied over 1700% in 3 months May 07, 2020 09:17 AM IST

    After a bout with NCLT, this stock has rallied over 1700% in 3 months

    Despite the sharp run-up, analysts feel that the scrip still has some steam left.

  • Investor wealth tumbles Rs 6.98 lakh crore in two days of market fall May 05, 2020 08:15 PM IST

    Investor wealth tumbles Rs 6.98 lakh crore in two days of market fall

    The BSE benchmark ended at 31,453.51, down 261.84 points or 0.83 percent on Tuesday.

Sections